The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead of its extended target action date of March 12, 2025, the FDA approved ...

People with eczema usually experience flare-ups during the winter season. During these periods, symptoms become worse and ...

More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...

“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with ...

The US Food and Drug Administration (FDA) has approved tapinarof cream, 1% for the treatment of atopic dermatitis (AD) in adults and pediatric patients 2 years of age and older. An aryl ...

The FDA has approved Organon’s Vtama (tapinarof) cream, 1%, for the treatment of atopic dermatitis (AD) in adults and children as young as two years of age. According to the company, the approval was ...

Therapy for atopic dermatitis is multi-faceted and encompasses ... Topical steroids are available in a wide variety of vehicles including creams, lotions, ointments, solutions, gels, and foams.

Winter season can trigger symptoms of atopic dermatitis by causing the skin to become dry and itchy in the cold weather. It ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...